NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹351 Cr | ₹157 Cr | ₹135 Cr | ₹27 Cr | ₹18 Cr |
What is the latest Short Term Provisions ratio of NATCO PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2026 | ₹351 Cr |
| Mar2025 | ₹157 Cr |
| Mar2024 | ₹135 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹18 Cr |
How is Short Term Provisions of NATCO PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹351 Cr | 123.52 | |
| Mar2025 | ₹157 Cr | 16.05 | |
| Mar2024 | ₹135 Cr | 400.74 | |
| Mar2023 | ₹27 Cr | 50.84 | |
| Mar2022 | ₹18 Cr | - | |
Compare Short Term Provisions of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,576.9 Cr | -0.2% | -8.3% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.2% |
-8.3% |
-5.1% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses